EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Transcriptomic dysregulation and autistic-like behaviors in Kmt2c haploinsufficient mice rescued by an LSD1 inhibitor

Takumi Nakamura iD, Toru Yoshihara, Chiharu Tanegashima, Mitsutaka Kadota, Yuki Kobayashi, Kurara Honda, Mizuho Ishiwata, Junko Ueda, Tomonori Hara, Moe Nakanishi, Toru Takumi iD, Shigeyoshi Itohara und 7 weitere

Molecular Psychiatry · 2024-09 · 29 (9) · 2888-2904

DOI: 10.1038/s41380-024-02479-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Psychiatry, online erschienen am 26.03.2024. Verfasst von Takumi Nakamura und 18 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Molecular Pathology of Psychiatric Disorders, RIKEN Center for Brain Science, Saitama, Japan. Hauptthemen laut MEDLINE: Haploinsufficiency, Autism Spectrum Disorder, Disease Models, Animal, Histone Demethylases. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development (AMED), MEXT | Japan Society for the Promotion of Science (JSPS).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent studies have consistently demonstrated that the regulation of chromatin and gene transcription plays a pivotal role in the pathogenesis of neurodevelopmental disorders. Among many genes involved in these pathways, KMT2C , encoding one of the six known histone H3 lysine 4 (H3K4) methyltransferases in humans and rodents, was identified as a gene whose heterozygous loss-of-function variants are causally associated with autism spectrum disorder (ASD) and the Kleefstra syndrome phenotypic spectrum. However, little is known about how KMT2C haploinsufficiency causes neurodevelopmental deficits and how these conditions can be treated. To address this, we developed and analyzed genetically engineered mice with a heterozygous frameshift mutation of Kmt2c ( Kmt2c +/fs mice) as a disease model with high etiological validity. In a series of behavioral analyses, the mutant mice exhibit autistic-like behaviors such as impairments in sociality, flexibility, and working memory, demonstrating their face validity as an ASD model. To investigate the molecular basis of the observed abnormalities, we performed a transcriptomic analysis of their bulk adult brains and found that ASD risk genes were specifically enriched in the upregulated differentially expressed genes (DEGs), whereas KMT2C peaks detected by ChIP-seq were significantly co-localized with the downregulated genes, suggesting an important role of putative indirect effects of Kmt2c haploinsufficiency. We further performed single-cell RNA sequencing of newborn mouse brains to obtain cell type-resolved insights at an earlier stage. By integrating findings from ASD exome sequencing, genome-wide association, and postmortem brain studies to characterize DEGs in each cell cluster, we found strong ASD-associated transcriptomic changes in radial glia and immature neurons with no obvious bias toward upregulated or downregulated DEGs. On the other hand, there was no significant gross change in the cellular composition. Lastly, we explored potential therapeutic agents and demonstrate that vafidemstat, a lysine-specific histone demethylase 1 (LSD1) inhibitor that was effective in other models of neuropsychiatric/neurodevelopmental disorders, ameliorates impairments in sociality but not working memory in adult Kmt2c +/fs mice. Intriguingly, the administration of vafidemstat was shown to alter the vast majority of DEGs in the direction to normalize the transcriptomic abnormalities in the mutant mice (94.3 and 82.5% of the significant upregulated and downregulated DEGs, respectively, P < 2.2 × 10 −16 , binomial test), which could be the molecular mechanism underlying the behavioral rescuing. In summary, our study expands the repertoire of ASD models with high etiological and face validity, elucidates the cell-type resolved molecular alterations due to Kmt2c haploinsufficiency, and demonstrates the efficacy of an LSD1 inhibitor that might be generalizable to multiple categories of psychiatric disorders along with a better understanding of its presumed mechanisms of action.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HaploinsufficiencyAutism Spectrum DisorderDisease Models, AnimalHistone DemethylasesTranscriptomeHistone-Lysine N-MethyltransferaseAutistic DisorderAnimalsMiceMaleIntellectual DisabilityChromosome DeletionCraniofacial AbnormalitiesFemaleMice, Inbred C57BLBehavior, AnimalBrainChromosomes, Human, Pair 9Heart Defects, Congenital

Substanzen

Histone DemethylasesHistone-Lysine N-MethyltransferaseKDM1a protein, mouse

Autor:innen und Institutionen

  • Laboratory for Molecular Pathology of Psychiatric Disorders, RIKEN Center for Brain Science, Saitama, Japan.
  • Department of Psychiatry and Behavioral Science, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Laboratory for Molecular Dynamics of Mental Disorders, RIKEN Center for Brain Science, Saitama, Japan.
  • Department of Life Sciences, Graduate School of Arts and Sciences, The University of Tokyo, Tokyo, Japan.
  • Institute of Laboratory Animals, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Laboratory for Phyloinformatics, RIKEN Center for Biosystems Dynamics Research, Hyogo, Japan.

ORCID-Profile: Takumi Nakamura, Toru Takumi, Atsushi Takata, Tadafumi Kato

Förderung

  • Japan Agency for Medical Research and Development (AMED)
  • MEXT | Japan Society for the Promotion of Science (JSPS)

Zitieren

APA

Nakamura, T., Yoshihara, T., Tanegashima, C., Kadota, M., Kobayashi, Y., Honda, K., Ishiwata, M., Ueda, J., Hara, T., Nakanishi, M., Takumi, T., Itohara, S., Kuraku, S., Asano, M., Kasahara, T., Nakajima, K., Tsuboi, T., Takata, A., & Kato, T. (2024). Transcriptomic dysregulation and autistic-like behaviors in Kmt2c haploinsufficient mice rescued by an LSD1 inhibitor. Molecular Psychiatry, 29(9), 2888-2904. https://doi.org/10.1038/s41380-024-02479-8

Vancouver

Nakamura T, Yoshihara T, Tanegashima C, Kadota M, Kobayashi Y, Honda K, et al. Transcriptomic dysregulation and autistic-like behaviors in Kmt2c haploinsufficient mice rescued by an LSD1 inhibitor. Molecular Psychiatry. 2024;29(9):2888-2904. doi:10.1038/s41380-024-02479-8

BibTeX
@article{Nakamura2024,
  author = {Nakamura, Takumi and Yoshihara, Toru and Tanegashima, Chiharu and Kadota, Mitsutaka and Kobayashi, Yuki and Honda, Kurara and Ishiwata, Mizuho and Ueda, Junko and Hara, Tomonori and Nakanishi, Moe and Takumi, Toru and Itohara, Shigeyoshi and Kuraku, Shigehiro and Asano, Masahide and Kasahara, Takaoki and Nakajima, Kazuo and Tsuboi, Takashi and Takata, Atsushi and Kato, Tadafumi},
  title = {Transcriptomic dysregulation and autistic-like behaviors in Kmt2c haploinsufficient mice rescued by an LSD1 inhibitor},
  journal = {Molecular Psychiatry},
  year = {2024},
  volume = {29},
  number = {9},
  pages = {2888--2904},
  doi = {10.1038/s41380-024-02479-8}
}
Kostenlos starten →